Syncom Formulations India Ltd reports Q2 FY27 consolidated revenue of ₹142.1 crore and net profit of ₹26.7 crore
- Revenue rose 13.2% sequentially and 16.8% year on year; net profit increased 7.3% and 60.5%, respectively.
- Derived EBITDA operating margin was approximately 22.5%; no exceptional items were reported.
- Board approved the results on 13 November 2026; auditors’ limited review found no indication of material misstatement.
